ADDvise Group AB (publ) (ADDV-A.ST)
SEK 11.2
(1.36%)
SEK 11.2
(1.36%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 611.8 Million SEK | 46.77% |
| 2022 | 416.84 Million SEK | 140.93% |
| 2021 | 173.01 Million SEK | 69.03% |
| 2020 | 102.36 Million SEK | -12.77% |
| 2019 | 117.34 Million SEK | 15.86% |
| 2018 | 101.28 Million SEK | 9.36% |
| 2017 | 92.61 Million SEK | 40.95% |
| 2016 | 65.7 Million SEK | 0.37% |
| 2015 | 65.46 Million SEK | 9.62% |
| 2014 | 59.71 Million SEK | 19.31% |
| 2013 | 50.05 Million SEK | 11.03% |
| 2012 | 45.08 Million SEK | 143.54% |
| 2011 | 18.51 Million SEK | 50.06% |
| 2010 | 12.33 Million SEK | 0.0% |
| 2009 | - SEK | -100.0% |
| 2008 | 11.62 Million SEK | 16.36% |
| 2007 | 9.99 Million SEK | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 148.2 Million SEK | -21.67% |
| 2024 Q2 | 143.4 Million SEK | -3.24% |
| 2024 Q3 | 145.6 Million SEK | 1.53% |
| 2023 Q2 | 149.1 Million SEK | 15.49% |
| 2023 Q3 | 144.3 Million SEK | -3.22% |
| 2023 FY | 611.8 Million SEK | 46.77% |
| 2023 Q4 | 189.2 Million SEK | 31.12% |
| 2023 Q1 | 129.1 Million SEK | 0.21% |
| 2022 FY | 416.84 Million SEK | 140.93% |
| 2022 Q1 | 70.84 Million SEK | 27.16% |
| 2022 Q2 | 112.6 Million SEK | 58.94% |
| 2022 Q3 | 104.55 Million SEK | -7.15% |
| 2022 Q4 | 128.83 Million SEK | 23.22% |
| 2021 FY | 173.01 Million SEK | 69.03% |
| 2021 Q1 | 32.06 Million SEK | 31.73% |
| 2021 Q2 | 40.34 Million SEK | 25.81% |
| 2021 Q3 | 44.88 Million SEK | 11.26% |
| 2021 Q4 | 55.71 Million SEK | 24.12% |
| 2020 FY | 102.36 Million SEK | -12.77% |
| 2020 Q2 | 26.63 Million SEK | -12.12% |
| 2020 Q1 | 30.31 Million SEK | 0.76% |
| 2020 Q4 | 24.34 Million SEK | 15.55% |
| 2020 Q3 | 21.06 Million SEK | -20.91% |
| 2019 Q3 | 27.51 Million SEK | -16.65% |
| 2019 FY | 117.34 Million SEK | 15.86% |
| 2019 Q1 | 26.73 Million SEK | 3.34% |
| 2019 Q2 | 33.01 Million SEK | 23.49% |
| 2019 Q4 | 30.08 Million SEK | 9.33% |
| 2018 Q2 | 25.35 Million SEK | -0.05% |
| 2018 Q4 | 25.87 Million SEK | 5.35% |
| 2018 FY | 101.28 Million SEK | 9.36% |
| 2018 Q1 | 25.36 Million SEK | -9.37% |
| 2018 Q3 | 24.55 Million SEK | -3.14% |
| 2017 Q2 | 24.17 Million SEK | 15.02% |
| 2017 FY | 92.61 Million SEK | 40.95% |
| 2017 Q4 | 27.98 Million SEK | 44.02% |
| 2017 Q3 | 19.43 Million SEK | -19.61% |
| 2017 Q1 | 21.01 Million SEK | 16.84% |
| 2016 FY | 65.7 Million SEK | 0.37% |
| 2016 Q3 | 13.49 Million SEK | 1.93% |
| 2016 Q4 | 17.98 Million SEK | 33.32% |
| 2016 Q2 | 13.23 Million SEK | -36.95% |
| 2016 Q1 | 20.99 Million SEK | 9.79% |
| 2015 FY | 65.46 Million SEK | 9.62% |
| 2015 Q1 | 14.1 Million SEK | -25.72% |
| 2015 Q2 | 13.76 Million SEK | -2.35% |
| 2015 Q3 | 18.47 Million SEK | 34.17% |
| 2015 Q4 | 19.12 Million SEK | 3.51% |
| 2014 Q4 | 18.98 Million SEK | 40.64% |
| 2014 Q1 | 13.79 Million SEK | 16.79% |
| 2014 Q2 | 13.44 Million SEK | -2.5% |
| 2014 Q3 | 13.49 Million SEK | 0.36% |
| 2014 FY | 59.71 Million SEK | 19.31% |
| 2013 Q4 | 11.81 Million SEK | -3.05% |
| 2013 FY | 50.05 Million SEK | 11.03% |
| 2013 Q1 | 13.04 Million SEK | -3.0% |
| 2013 Q2 | 13.01 Million SEK | -0.25% |
| 2013 Q3 | 12.18 Million SEK | -6.39% |
| 2012 Q3 | 10.61 Million SEK | -4.39% |
| 2012 Q1 | 10.03 Million SEK | 108.44% |
| 2012 Q2 | 11.1 Million SEK | 10.67% |
| 2012 Q4 | 13.45 Million SEK | 26.74% |
| 2012 FY | 45.08 Million SEK | 143.54% |
| 2011 FY | 18.51 Million SEK | 50.06% |
| 2011 Q3 | 4.57 Million SEK | -2.08% |
| 2011 Q4 | 4.81 Million SEK | 5.13% |
| 2011 Q1 | 4.74 Million SEK | 3.54% |
| 2011 Q2 | 4.67 Million SEK | -1.41% |
| 2010 FY | 12.33 Million SEK | 0.0% |
| 2010 Q4 | 4.57 Million SEK | 88.44% |
| 2010 Q3 | 2.43 Million SEK | -11.64% |
| 2010 Q2 | 2.75 Million SEK | 6.67% |
| 2010 Q1 | 2.57 Million SEK | 0.0% |
| 2009 Q4 | - SEK | 0.0% |
| 2009 FY | - SEK | -100.0% |
| 2009 Q2 | 3.12 Million SEK | -4.29% |
| 2009 Q1 | 3.26 Million SEK | 0.15% |
| 2009 Q3 | - SEK | -100.0% |
| 2008 FY | 11.62 Million SEK | 16.36% |
| 2008 Q1 | 2.66 Million SEK | 4.88% |
| 2008 Q2 | 2.38 Million SEK | -10.43% |
| 2008 Q4 | 3.25 Million SEK | 0.0% |
| 2007 Q4 | 2.54 Million SEK | 0.0% |
| 2007 FY | 9.99 Million SEK | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acarix AB (publ) | 82.85 Million SEK | -638.443% |
| ADDvise Group AB (publ) | 611.8 Million SEK | 0.0% |
| Arcoma AB | 53.25 Million SEK | -1048.877% |
| Bactiguard Holding AB (publ) | 4.96 Million SEK | -12212.336% |
| BICO Group AB (publ) | 2.84 Billion SEK | 78.521% |
| Boule Diagnostics AB (publ) | 210.44 Million SEK | -190.719% |
| CellaVision AB (publ) | 295.99 Million SEK | -106.696% |
| Clinical Laserthermia Systems AB (publ) | 68.93 Million SEK | -787.567% |
| Chordate Medical Holding AB (publ) | 1.3 Million SEK | -46631.435% |
| C-Rad AB (publ) | 3.8 Million SEK | -16000.0% |
| Duearity AB (publ) | 21.58 Million SEK | -2734.376% |
| Dignitana AB (publ) | 74.73 Million SEK | -718.615% |
| Episurf Medical AB (publ) | 2.7 Million SEK | -22559.259% |
| Getinge AB (publ) | 10.75 Billion SEK | 94.314% |
| Scandinavian Real Heart AB (Publ) | 18.22 Million SEK | -3256.272% |
| Iconovo AB (publ) | 63.35 Million SEK | -865.679% |
| Integrum AB (publ) | 90.57 Million SEK | -575.488% |
| Luxbright AB (publ) | 23.09 Million SEK | -2549.572% |
| Mentice AB (publ) | 237.06 Million SEK | -158.078% |
| OssDsign AB (publ) | 175.6 Million SEK | -248.403% |
| Paxman AB (publ) | 133.8 Million SEK | -357.25% |
| Promimic AB (publ) | 48.55 Million SEK | -1160.092% |
| Qlife Holding AB (publ) | 162.38 Million SEK | -276.759% |
| SciBase Holding AB (publ) | 69.97 Million SEK | -774.3% |
| ScandiDos AB (publ) | 61.03 Million SEK | -902.326% |
| Sectra AB (publ) | 39.06 Million SEK | -1466.188% |
| Sedana Medical AB (publ) | 174.52 Million SEK | -250.545% |
| Senzime AB (publ) | 141.51 Million SEK | -332.316% |
| SpectraCure AB (publ) | 12.12 Million SEK | -4944.525% |
| Stille AB | 87.21 Million SEK | -601.453% |
| Vitrolife AB (publ) | 5.56 Billion SEK | 89.01% |
| Xvivo Perfusion AB (publ) | 440.92 Million SEK | -38.754% |